We are live on
!
Find out more
Fayez Sarofim & Co Portfolio holdings
AUM
$42.5B
1-Year Est. Return
18.19%
This Fund
S&P 500
This Quarter
Est. Return
-5.91%
1 Year Est. Return
+18.19%
3 Year Est. Return
+63.85%
5 Year Est. Return
+89.78%
10 Year Est. Return
+309.54%
AUM
$25.3B
AUM Growth
-$2.07B
(-7.6%)
Cap. Flow
-$344M
Cap. Flow
% of AUM
-1.36%
Top 10 Holdings %
Top 10 Hldgs %
42.44%
Holding
294
New
5
Increased
61
Reduced
122
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$48.2M |
| 2 |
ExxonMobil
XOM
|
+$17.9M |
| 3 |
HES
Hess
HES
|
+$13.5M |
| 4 |
Visa
V
|
+$13.2M |
| 5 |
EOG Resources
EOG
|
+$7.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$57M |
| 2 |
TotalEnergies
TTE
|
+$47.8M |
| 3 |
Apple
AAPL
|
+$41.4M |
| 4 |
K
Kellanova
K
|
+$40.6M |
| 5 |
Organon & Co
OGN
|
+$33.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.28% |
| 2 | Consumer Staples | 19.28% |
| 3 | Financials | 18.16% |
| 4 | Energy | 12.21% |
| 5 | Healthcare | 11.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Invesco
IVZ
$13.9B
| $146K | ﹤0.01% |
10,691
| – | – |
|
277
Plains GP Holdings
PAGP
$5.54B
| $125K | ﹤0.01% |
11,500
| – | – |
|
|
PLXP
278
DELISTED
PLx Pharma Inc. Common Stock
PLXP
| $9K | ﹤0.01% |
13,729
| – | – |
|
279
AstraZeneca
AZN
$254B
| – | – |
-1,673
| Closed | -$221K |
|
280
Bruker
BRKR
$8.02B
| – | – |
-3,290
| Closed | -$206K |
|
281
Conagra Brands
CAG
$7.1B
| – | – |
-12,676
| Closed | -$434K |
|
282
Energy Transfer Partners
ET
$74B
| – | – |
-14,672
| Closed | -$146K |
|
283
GSK
GSK
$100B
| – | – |
-5,571
| Closed | -$303K |
|
284
HP
HPQ
$30.7B
| – | – |
-7,876
| Closed | -$258K |
|
285
iShares Russell 1000 Growth ETF
IWF
$124B
| – | – |
-20,000
| Closed | -$1.09M |
|
|
LEG
286
DELISTED
Leggett & Platt
LEG
| – | – |
-82,236
| Closed | -$2.84M |
|
287
Lamb Weston
LW
$6.63B
| – | – |
-3,024
| Closed | -$216K |
|
288
3M
MMM
$83.6B
| – | – |
-36,998
| Closed | -$4M |
|
289
ServiceNow
NOW
$147B
| – | – |
-6,210
| Closed | -$591K |
|
290
J.M. Smucker
SJM
$13B
| – | – |
-36,624
| Closed | -$4.69M |
|
291
Sanofi
SNY
$104B
| – | – |
-11,180
| Closed | -$559K |
|
292
Teleflex
TFX
$5.52B
| – | – |
-2,312
| Closed | -$568K |
|
293
Travelers Companies
TRV
$78.9B
| – | – |
-2,435
| Closed | -$412K |
|
|
WWE
294
DELISTED
World Wrestling Entertainment
WWE
| – | – |
-25,070
| Closed | -$1.57M |
|
Similar funds
PCH
GAM
Fayez Sarofim & Co's Q3 2022 Portfolio in Review
As of Q3 2022, Fayez Sarofim & Co held 294 positions worth $25.3B, down 7.6% from $27.4B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Fayez Sarofim & Co's Q3 2022 filing shows 5 new, 61 increased, 122 reduced and 16 closed positions. Its largest new stake was Toyota: 1,680 shares worth $219K. The largest sale was Alphabet (Google) Class C, an estimated $57M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Consumer Staples and Financials.
- Fayez Sarofim & Co's largest Q3 2022 buy was Toyota: 1,680 shares worth $219K.
- Fayez Sarofim & Co added most to Novo Nordisk in Q3 2022, an estimated $48.2M increase.
- Fayez Sarofim & Co's biggest Q3 2022 reduction was Alphabet (Google) Class C, cutting an estimated $57M.
- Fayez Sarofim & Co fully exited J.M. Smucker in Q3 2022, selling an estimated $4.69M.
- Fayez Sarofim & Co's ten largest holdings make up 42% of its $25.3B portfolio in Q3 2022.
- Fayez Sarofim & Co opened 5 new positions and closed 16 in Q3 2022.
- Fayez Sarofim & Co's portfolio value fell 7.6% quarter-over-quarter to $25.3B.
Based on Fayez Sarofim & Co's 13F filing for Q3 2022, filed 15 Nov 2022.